Stocks
Agios Pharmaceuticals (AGIO) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -337.7 | -380.5 | -384.9 | -420.1 | -467.0 | -470.3 | ||
| Changes by years, y/y, % | +4% | +13% | +1% | +9% | +11% | +7.4% | |||
Agios Pharmaceuticals. EBITDA US GAAP, bln rub
Agios Pharmaceuticals. EBITDA US GAAP, changes, %
Agios Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Agios Pharmaceuticals (AGIO) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -105.4 | -125.8 | -115.5 | -120.3 | -108.7 | -470.3 | |
| Changes by years, y/y, % | +16% | +21% | +14% | -3% | +3% | |||
| Changes by quarters, q/q, % | -15% | +19% | -8% | +4% | -10% | |||
